Ono Pharmaceutical Co Ltd 2024 Integrated Report
The report presents ONO's value creation process, including consolidated human capital data and environmental and human-rights priorities. It reports 82,666 MWh of energy consumption and 3,853 consolidated employees, and describes a 2035 zero-greenhouse-gas-emissions ambition alongside a 2030 Scope 3 reduction target. It also explains the Group-wide human-rights policy and due-diligence mechanism.
Company: Ono Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2024
Type: Integrated Report
Pages: 100
Back to company
Ono Pharmaceutical Co Ltd
Corporate Report
The report presents ONO's value creation process, including consolidated human capital data and environmental and human-rights priorities. It reports 82,666 MWh of energy consumption and 3,853 consolidated employees, and describes a 2035 zero-greenhouse-gas-emissions ambition alongside a 2030 Scope 3 reduction target. It also explains the Group-wide human-rights policy and due-diligence mechanism.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Apr 1, 2023 - Mar 31, 2024
Fiscal Year
2024
Published
Sep 1, 2024
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Net Zero Target
Employees